Yu, Ying,Denker, Andrew Evan,Sadekova, Svetlana,Phan, Uyen Truong,Kastelein, Robert A.,Kaufman, David Ross,Coffman, Robert L.,Guiducci, Cristiana,Janssen, Robert S.
申请号：
AU2016271018
公开号：
AU2016271018A1
申请日:
2016.05.26
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a Toll-like receptor 9 (TLR9) agonist that is a CpG-C type oligonucleotide, and the use of the combination therapies for the treatment of cancer.
